13-48362859-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000321.3(RB1):c.763C>T(p.Arg255*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000321.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.763C>T | p.Arg255* | stop_gained | Exon 8 of 27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.763C>T | p.Arg255* | stop_gained | Exon 8 of 27 | NP_001394094.1 | ||
RB1 | NM_001407166.1 | c.763C>T | p.Arg255* | stop_gained | Exon 8 of 17 | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.763C>T | p.Arg255* | stop_gained | Exon 8 of 27 | 1 | NM_000321.3 | ENSP00000267163.4 | ||
RB1 | ENST00000467505.5 | n.*131C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | ENSP00000434702.1 | ||||
RB1 | ENST00000467505.5 | n.*131C>T | 3_prime_UTR_variant | Exon 3 of 3 | 1 | ENSP00000434702.1 | ||||
RB1 | ENST00000650461.1 | c.763C>T | p.Arg255* | stop_gained | Exon 8 of 27 | ENSP00000497193.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:6
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Case and Pedigree Information: BILATERAL CASES:14, UNILATERAL CASES:2, TOTAL CASES:16, PEDIGREES:15. ACMG Codes Applied:PVS1, PM2, PS4M -
- -
- -
The RB1 c.763C>T variant is classified as Pathogenic (PVS1, PS4_Moderate, PM2) The RB1 c.763C>T variant is a single nucleotide change which is predicted to result in premature termination of the protein product at codon 255 (PVS1). The variant has been reported in probands with a clinical presentation of either sporadic or familial retinoblastoma (PS4_Moderate). This variant is absent from population databases (PM2). The variant has been reported in dbSNP (rs587778842) and in the HGMD database: CM951104. It has been reported as Pathogenic by other diagnostic laboratories (ClinVar Variation ID: 126820). -
This sequence change creates a premature translational stop signal (p.Arg255*) in the RB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with retinoblastoma (PMID: 7704558, 22963398, 24225018, 25754945, 27155049). ClinVar contains an entry for this variant (Variation ID: 126820). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:3
- -
PVS1, PS4, PM2_SUP -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R255* pathogenic mutation (also known as c.763C>T), located in coding exon 8 of the RB1 gene, results from a C to T substitution at nucleotide position 763. This changes the amino acid from an arginine to a stop codon within coding exon 8. This alteration has been reported in multiple individuals with either sporadic or familial retinoblastoma (Zhang L et al. Tumour Biol. 2015 Apr;36:2409-20; Thirumalairaj K et al. J. Hum. Genet. 2015 Sep;60:547-52; Taylor M et al. Hum. Mutat. 2007 Mar;28:284-93; Rushlow D et al. Hum. Mutat. 2009 May;30:842-51; Sagi M et al. Fam. Cancer. 2015 Sep;14:471-80; Blanquet V et al. Hum. Mol. Genet. 1994 Jul;3:1185-6). Some individuals with sporadic retinoblastoma were found to be mosaic for this alteration (Rushlow D et al. Hum. Mutat. 2009 May;30:842-51; Sagi M et al. Fam. Cancer. 2015 Sep;14:471-80). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at